10x Genomics Blog Dec 2, 2025 10x Genomics Comments on Second UPC Preliminary Injunction Decis - GuruFocus
Endpoints News Dec 2, 2025 ARCH, Parker Institute build next big oncology bet with suite of programs and startup acquisition
Cell Dec 2, 2025 An archaeal transcription factor bridges prokaryotic and eukaryotic regulatory paradigms
FierceBiotech Dec 2, 2025 Imvax takes brain cancer cell therapy to FDA, betting survival hit will overshadow primary miss
FierceBiotech Dec 2, 2025 Tiziana to spin out IL-6 drug into new company, citing Big Pharma's interest in modality
FierceBiotech Dec 2, 2025 Roche's point-of-care whooping cough test greenlighted in US, Europe as cases surge
Endpoints News Dec 2, 2025 Pfizer culls ulcerative colitis candidate; Tiziana to try spinning out IL-6 drug
10x Genomics Blog Dec 2, 2025 TXG: Morgan Stanley Downgrades 10x Genomics, Raises Price Target | TXG Stock News - GuruFocus
10x Genomics Blog Dec 2, 2025 TXG: Morgan Stanley Downgrades 10x Genomics, Raises Price Target - GuruFocus